PFS Investments’s Merck MRK Stock Holding History

PFS Investments’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$10.8M	Buy	93,566 +4,682	+5%	+$532K	0.18%	124
2023 Q1	$9.98M	Buy	88,884 +4,894	+6%	+$528K	0.17%	128
2022 Q4	$9.32M	Buy	83,990 +5,861	+8%	+$599K	0.17%	125
2022 Q3	$6.73M	Buy	78,129 +3,995	+5%	+$357K	0.12%	138
2022 Q2	$6.76M	Buy	74,134 +8,145	+12%	+$722K	0.14%	150
2022 Q1	$5.41M	Buy	65,989 +5,117	+8%	+$403K	0.1%	186
2021 Q4	$4.67M	Buy	60,872 +3,986	+7%	+$317K	0.09%	197
2021 Q3	$4.7M	Buy	56,886 +1,871	+3%	+$142K	0.1%	185
2021 Q2	$4.29M	Sell	55,015 -3,278	-6%	-$244K	0.1%	180
2021 Q1	$4.29M	Sell	58,293 -3,900	-6%	-$288K	0.11%	169
2020 Q4	$5.04M	Buy	62,193 +6,132	+11%	+$469K	0.14%	144
2020 Q3	$4.44M	Buy	56,061 +5,798	+12%	+$454K	0.15%	137
2020 Q2	$3.71M	Buy	50,263 +9,368	+23%	+$705K	0.14%	127
2020 Q1	$3M	Buy	40,895 +12,961	+46%	+$1.02M	0.13%	121
2019 Q4	$2.42M	Buy	27,934 +12,532	+81%	+$1.03M	0.09%	135
2019 Q3	$1.24M	Buy	15,402 +7,537	+96%	+$604K	0.05%	134
2019 Q2	$642K	Buy	+7,865	New	+$602K	0.03%	137

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PFS Investments's MRK Position: Q2 2023 in Review

PFS Investments increased its Merck (MRK) stake by 5.3% in Q2 2023, buying an estimated $532K and bringing the position to 93,566 shares worth $10.8M. The position accounts for 0.18% of the portfolio, ranked #124.

PFS Investments first reported a position in MRK in Q2 2019 and has held it in 17 quarters since. 3,257 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

PFS Investments held 93,566 shares of Merck worth $10.8M as of Q2 2023.
PFS Investments bought 4,682 Merck shares in Q2 2023, an estimated $532K.
Merck made up 0.18% of PFS Investments's portfolio in Q2 2023, its #124 holding.
PFS Investments first reported a position in Merck in Q2 2019 and has held it in 17 quarters since.
3,257 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.